HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vijaya Knight Selected Research

Complement C3d (Complement 3d)

7/2022Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vijaya Knight Research Topics

Disease

9Infections
01/2022 - 03/2014
5COVID-19
01/2022 - 11/2020
2Common Variable Immunodeficiency
01/2022 - 07/2015
2Rheumatoid Arthritis
10/2021 - 07/2021
2Lung Diseases (Lung Disease)
01/2021 - 09/2013
2Hypersensitivity (Allergy)
11/2018 - 11/2018
1Interstitial Lung Diseases (Interstitial Lung Disease)
07/2022
1Reinfection
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1IgG Deficiency
01/2022
1Mycoses (Diseases, Fungus)
01/2022
1Arthritis (Polyarthritis)
10/2021
1Osteoarthritis
10/2021
1Pain (Aches)
10/2021
1Emerging Communicable Diseases (Emerging Infectious Diseases)
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Pulmonary Alveolar Proteinosis
01/2021
1Opportunistic Infections (Opportunistic Infection)
01/2021
1Neutropenia
01/2020
1Glycogen Storage Disease IB
01/2020
1Anaphylaxis (Anaphylactic Shock)
01/2020
1Type 2 Diabetes Mellitus (MODY)
01/2020
1Glycogen Storage Disease (Glycogenosis)
01/2020
1Hypoglycemia (Reactive Hypoglycemia)
01/2020
1Rare Diseases (Rare Disease)
01/2020
1Immune Complex Diseases (Immune Complex Disease)
11/2018
1Eczema
11/2018
1Dermatitis
11/2018
1Phenylketonurias (Phenylketonuria)
11/2018
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018
1Chronic Mucocutaneous Candidiasis
01/2016
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016
1Communicable Diseases (Infectious Diseases)
01/2016
1Bacterial Infections (Bacterial Infection)
01/2016
1Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
12/2015

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
01/2022 - 01/2016
4AutoantibodiesIBA
01/2021 - 03/2014
3Interferon-gamma (Interferon, gamma)IBA
01/2022 - 03/2014
3AntibodiesIBA
01/2021 - 01/2016
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2022 - 01/2022
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022 - 01/2021
2Interferon-alpha (Interferon Alfa)IBA
01/2022 - 01/2016
2Pharmaceutical PreparationsIBA
10/2021 - 07/2021
2Immunoglobulin G (IgG)IBA
10/2021 - 11/2020
2Investigational DrugsIBA
01/2021 - 11/2020
2Neutralizing AntibodiesIBA
01/2021 - 01/2021
2Immunoglobulin E (IgE)IBA
11/2018 - 11/2018
2InterferonsIBA
01/2016 - 03/2014
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2022
1Interleukin-2 Receptors (IL 2 Receptor)IBA
07/2022
1Complement C3d (Complement 3d)IBA
07/2022
1NF-kappa B (NF-kB)IBA
07/2022
1Sirolimus (Rapamycin)FDA Link
07/2022
1Epstein-Barr Virus Nuclear AntigensIBA
07/2022
1L-SelectinIBA
07/2022
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
07/2022
1Basic Helix-Loop-Helix Transcription FactorsIBA
07/2022
1Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA
07/2022
1Leukocyte Common Antigens (CD45 Antigen)IBA
07/2022
1NF-kappaB-Inducing KinaseIBA
07/2022
1IgG Receptors (Fc gamma RI)IBA
07/2022
1I-kappa B KinaseIBA
07/2022
1Phosphotransferases (Kinase)IBA
07/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1VaccinesIBA
01/2022
1Pyridinolcarbamate (P23)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
10/2021
1ChemokinesIBA
10/2021
1Matrix Metalloproteinases (MMPs)IBA
10/2021
1AntigensIBA
10/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021
1Surface-Active Agents (Surfactants)IBA
01/2021
1APTIBA
01/2021
1Viral RNAIBA
11/2020
1empagliflozinIBA
01/2020
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2020
1Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA
01/2020
1EnzymesIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
01/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2020
11,5-anhydroglucitol-6-phosphateIBA
01/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020
1Interleukin-13IBA
01/2020
1Sodium-Glucose Transport ProteinsIBA
01/2020
1Phenylalanine (L-Phenylalanine)FDA Link
11/2018
1Antigen-Antibody Complex (Immune Complex)IBA
11/2018
1Ammonia-LyasesIBA
11/2018
1pegvaliaseIBA
11/2018
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
11/2018
1amotosalenIBA
01/2018
1Interleukin-17 (Interleukin 17)IBA
01/2016
1Epoxy ResinsFDA Link
12/2015

Therapy/Procedure

3Therapeutics
01/2022 - 07/2021
1Length of Stay
01/2022
1Precision Medicine
07/2021
1Immunotherapy
01/2021
1Off-Label Use
01/2020
1Lung Transplantation
12/2015